Nearly 12 million men in the U.S. suffer from symptoms related to benign prostatic hyperplasia (BPH), an enlargement of the prostate that can cause issues such as frequent and weak urinary streams and sleep deprivation from getting up repeatedly during the night to urinate. Since traditional BPH therapies such as daily medications and more invasive or surgical procedures often result in unwanted side effects and complications, more than 54 percent of men who would benefit from treating their BPH choose not to do anything1. With today’s national introduction of the FDA-cleared Rezūm® System, NxThera provides urologists and their patients suffering from symptomatic BPH with a new, safe and effective minimally-invasive, office-based treatment option which improves quality of life and preserves sexual function2 – one of the main reasons many men choose to forego medications or more invasive procedures.
“Men suffering from BPH are constantly evaluating the trade-offs between maintaining their current declined quality of life or treating their BPH symptoms and possibly incurring long term side effects,” said Dr. Kia Michel, M.D., a urologist at Comprehensive Urology in Los Angeles who recently performed the procedure as part of a nationally televised segment on prostate health. “Of all the minimally-invasive BPH treatments I’ve performed, Rezūm is the most effective and most versatile treatment available to patients – and the results have been excellent.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7933151-nxthera-rezum-therapy/
Do you feel financially prepared for the future? If you’re not completely confident in your response, you’re not alone. In fact, a recent survey conducted by Research Now Group, Inc. and commissioned by Fifth Third Private Bank (NASDAQ: FITB) found that nearly half of those surveyed have serious concerns that they may outlive their money in retirement.
The Bank launched the survey to understand families’ financial planning pain points and gain insight into how the process could be simplified through its new platform, Life360.
“The study confirmed the anxiety that clients have shared with our advisors is reflective of similar concerns nationally,” said Phil McHugh, executive vice president and head of Wealth and Asset Management at Fifth Third. “Much of that anxiety stems from a lack of clearly articulated financial goals and alignment around achieving them. Our Life360 platform works to help simplify, focus and holistically address these critical aspects of the financial planning process.”
To view the multimedia release go to:
https://www.multivu.com/players/English/7723854-fifth-third-bank-life360
Sickle cell disease (SCD) is an inherited, lifelong chronic disorder affecting nearly 100,000 Americans and a growing global health problem that will touch nearly 30 percent more people globally in the next three decades. Though new approaches to managing SCD have led to improvements in diagnosis and supportive care, people living with the disease still have severe complications to overcome. Many are unable to access quality care and are limited by a lack of effective treatment options.
In an effort to identify unmet medical needs for people with SCD, the American Society of Hematology (ASH), along with other groups, issued the State of Sickle Cell Disease: 2016 Report, evaluating the disease in four priority areas — access to care, training and professional education, research and clinical trials, and global health. The report shows that significant improvements are needed across all areas and that, though patients are living longer, the system of care needs to change to ensure a better quality of life. To address these challenges, ASH launched the Sickle Cell Disease Coalition along with more than 20 other organizations who are issuing a call to action that will amplify the voice of the SCD community, promote SCD awareness, and transform SCD care both in the United States and around the globe.
To view the multimedia release go to:
http://www.multivu.com/players/English/7903251-american-society-hematology-sickle-cell-coalition/
Fifth Third Bank (NASDAQ: FITB) today announced a first-ever, company-wide initiative to deliver its Empower U financial literacy courses throughout its 10-state footprint. The Empower U initiative brings Fifth Third together with more than 60 local nonprofit organizations in outreach to nearly 3,000 individuals in the communities it serves.
According to a recent study commissioned by Fifth Third, more than 40 percent of Americans feel they could benefit from professional advice about their day-to-day finances. Empower U, one of the Bank’s signature L.I.F.E. (Lives Improved through Financial Empowerment®) programs, is designed to do just that.
To view the multimedia release go to:
http://www.multivu.com/players/English/7723853-fifth-third-bank-empower-u-initiative/
Pilot Corporation of America (Pilot Pen) is once again teaming up with STOMP Out Bullying, the leading national bullying and cyberbullying prevention organization, to invite parents and students to help end the bullying epidemic through their “Erase Bullying for Good” campaign. The campaign aims to help erase bullying in U.S. schools by utilizing the funds raised from sales of the FriXion Clicker erasable gel ink pen, which allows one to “Write Fearlessly” through its smooth writing and clean erasing capabilities, to raise awareness and support STOMP Out Bullying’s educational and assistance programs. Pilot is donating a total of $125,000 to help address this serious issue that affects nearly one in four American students.
“Every year Pilot Pen strives to provide students with the best tools to tackle the school year in the form of high quality writing instruments, but after witnessing the increasing prevalence of bullying and cyberbullying in America we also want to help erase this serious issue in our schools,” said Ariann Langsam, Director of Marketing at Pilot Corporation of America. “STOMP Out Bullying’s programs are a wonderful resource for those affected by bullying and Pilot is proud to continue supporting the organization’s wonderful mission.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7865151-pilot-pen-erase-bullying-for-good/
Zelda was found filthy, hungry and matted. Barely recognizable as a dog, her rescuers cleaned her up to reveal a tiny Shih Tzu. Unfortunately, Zelda’s story is similar to the nearly 8 million other animals entering shelters each year. That’s why Wahl has teamed up with GreaterGood.org to donate funds and grooming supplies to shelters nationwide. The goal: Transform more than 20,000 dogs this year and get them ready for adoption.
“Due to lack of resources, less than half of dogs entering shelters are getting the grooming they desperately need,” says Shay Moeller, pet product manager for Wahl. “First impressions are crucial, and without proper grooming, many of these dogs are perceived to be ‘damaged goods.’ By providing shelters with much-needed grooming supplies, we can transform these dogs into the healthy, fun loving pets they really are.”
To view the multimedia release go to:
http://www.multivu.com/players/English/7828751-wahl-dirty-dogs-contest/
Abbott announced today that the U.S. Food and Drug Administration (FDA) has approved the Tecnis Symfony® Intraocular Lenses for the treatment of cataracts. The first in a new category of intraocular lenses (IOLs), the Tecnis Symfony lenses are the only lenses in the United States that provide a full range of continuous high-quality vision following cataract surgery, while also mitigating the effects of presbyopia by helping people focus on near objects. The FDA approval includes a version of the lens for people with astigmatism, the Tecnis Symfony Toric IOL.
Cataracts are a common condition, with almost 4 million cataract surgeries performed each year, and that number is expected to increase.1 By age 80, more than half of all Americans either have a cataract or have had cataract surgery.2 However, cataracts do not just impact seniors. In 2016 it is estimated that nearly one in four cataract surgeries will be performed on people younger than 65.1 Many people who have cataracts experience other problems with their vision, such as presbyopia and astigmatism, which the Symfony lenses also address. Presbyopia, which affects most people over age 40, means people have lost the ability to focus on objects up close and often require glasses to perform near visual tasks. Astigmatism is when the cornea is misshapen, which causes blurry or distorted vision.
To view the multimedia release go to:
http://www.multivu.com/players/English/7870151-abbott-intraocular-lenses/
Quinny and Maxi-Cosi, premier European brands owned by Dorel Juvenile, a segment of Dorel Industries (TSX: DII.B, DII.A), and the world's largest juvenile products manufacturer in its categories, today announced the arrival of the Rachel Zoe x Quinny and Maxi-Cosi Collection, a luxurious collection of strollers, car seats and baby gear designed by Rachel Zoe. The collection, now available for purchase at Nordstrom, followed by retailers globally later this year, retails in the US from $229 to $899 and includes the Quinny® Moodd stroller, the Maxi-Cosi® Mico Max 30 and Maxi-Cosi® Pria 85 car seats, and Quinny Diaper Bag.
With nearly two decades of experience in design and fashion, Zoe has become a household name, embodying modern, effortless glamour and timeless sophistication. From designing her eponymous ready-to-wear, jewelry, and footwear collection and authoring two New York Times bestselling books, to serving as Editor-in-Chief of digital lifestyle destination The Zoe Report, Rachel’s influence reaches millions daily and continues to grow. As a mother of two young boys, Zoe’s influence also extends from fashion, beauty and style into the worlds of parenthood, home, entertaining and lifestyle.
To view the multimedia release go to:
http://www.multivu.com/players/English/7851951-dorel-juvenile-rachel-zoe-nordstrom/
For decades, students with full-time jobs, families at home or several years between credit hours were considered outliers, or “non-traditional students.” Today, however, they constitute nearly 75 percent of America’s undergraduate student body, according to the National Center for Education Statistics. This “New Majority” consists of working adults who are managing the demands of school, work and family life, and are looking at higher education with a different set of expectations and priorities.
At schools like DeVry University, the New Majority students are finding the flexibility they need. Whether they’re looking for flexible course schedules, stackable certification programs or the ability to mix and match different modes of immersive learning, these students turn to DeVry University for degree programs and skill sets that can be immediately applied in the workplace.
To view the multimedia release go to:
http://www.multivu.com/players/English/7693951-devry-degree-programs-for-new-majority/
SC Johnson, the world's leading manufacturer of pest control products, is using its 60 years of insect expertise to educate consumers as the Zika virus continues to spread. Immediately following the initial outbreak in Brazil, the company assembled its experts and began developing educational resources for consumers to understand how to best protect themselves against mosquitoes that may carry disease.
In addition to educating consumers, SC Johnson is actively working with organizations around the world to donate and distribute product to those in need. In coordination with the U.S. Centers for Disease Control and Prevention (CDC) Foundation, SC Johnson supported the Zika Action Plan Summit held by the White House and the CDC on April 1, and also donated to the CDC's Zika Prevention Kits. Additional donations have been made to AmeriCares, the Rio de Janeiro-based Children’s Health Association and the County of Hawaii Civil Defense Agency.
For nearly 60 years, SC Johnson entomologists have studied insects at the Entomology Research Center in Racine, Wis., the world's largest private, urban entomology research center. In their research, they help SC Johnson create products that consumers can trust and to provide them with the right product for their pest control needs. SC Johnson is the world's largest manufacturer of insect repellent and household insecticides, including OFF!®, Raid®, Autan® and Baygon®.
To view the multimedia release go to:
http://www.multivu.com/players/English/7787731-sc-johnson-zika-mosquito-protection/
Today, Chick-fil-A® launches Chick-fil-A One ™ – a mobile app that gives customers a new way to experience Chick-fil-A. The app is designed to give customers more choices to better meet their needs, including the ability to customize their meal, order and pay in advance and skip the line at the register, speeding up the process of waiting at the counter or drive-thru.
According to a recent survey commissioned by Chick-fil-A, 82 percent of millennial parents say they would do almost anything to avoid long lines at fast food restaurants when they are with their children. In fact, nearly half (48 percent) said they would rather not eat at all than stand in a line.
To view the multimedia release go to:
http://www.multivu.com/players/English/7764751-chick-fil-a-one-app/
Society for Science & the Public (Society) today announced that Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) is the new title sponsor of the Science Talent Search. Selected through a competitive process that garnered interest from the nation’s leading companies and philanthropists, Regeneron will become only the third sponsor in 75 years of the nation’s oldest and most prestigious high school science competition.
The new sponsorship will be celebrated at a special event today at the American Museum of Natural History, which is known for its extensive science education program. The event will be hosted by astrophysicist Neil deGrasse Tyson, Ph.D., Frederick P. Rose director of the Hayden Planetarium at the American Museum of Natural History, and can be viewed via webcast at 9:00 a.m. EDT at http://edge.media-server.com/m/go/sciencetalentsearch.
Regeneron is committing $100 million to support the Science Talent Search and other Society programs through 2026 and will assume title sponsorship of the competition effectively immediately. As part of its commitment, Regeneron is nearly doubling the overall award distribution to $3.1 million annually, increasing the top award to $250,000, and doubling the awards for the top 300 young scientists and their schools to $2,000 each. During its history, the Science Talent Search has provided more than $25 million in awards to over 8,500 students and schools.
To view the multimedia release go to:
http://www.multivu.com/players/English/7846351-regeneron-science-talent-search/
